Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.4K
Overview
85.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor heart injury caused by liver needle biopsy during multi-organ procurement surgery: A case report.

World journal of transplantation·2026
Same author

Spatial transcriptomics reveals differences in bronchus-associated lymphoid tissue composition in stable and rejecting human lung allografts.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Trends in lung cancer survival: superior outcomes in US veterans compared to general population.

JNCI cancer spectrum·2026
Same author

A single-center experience of 2000 adult lung transplants.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Circulating T cell-specific extracellular vesicles as biomarkers of acute cellular rejection after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Technology-Enabled Remote Patient Monitoring and Education to Improve Kidney Transplant Knowledge, Access, and Post-Transplant Care: A Narrative Review.

Current transplantation reports·2026
Same journal

Mediterranean Diet: How Useful is it in Kidney Transplant Patients?

Current transplantation reports·2026
Same journal

Cellular Therapies in Transplantation - Regulatory T Cell Therapies and Virus Specific Therapies.

Current transplantation reports·2025
Same journal

Non-invasive approaches to living donor nephrectomy: Best practices and innovations.

Current transplantation reports·2025
Same journal

Non-HLA Genetics and Application to Living Donor Candidates.

Current transplantation reports·2025
Same journal

The Functional Adaptability of Hyporesponsive T Cells and its Impact on Transplant Outcomes.

Current transplantation reports·2025
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.2K

Update on Chronic Lung Allograft Dysfunction.

Jason M Gauthier1, Ramsey R Hachem2, Daniel Kreisel3

  • 1Department of Surgery, Washington University in St. Louis, Saint Louis, MO.

Current Transplantation Reports
|January 17, 2017
PubMed
Summary
This summary is machine-generated.

Chronic lung allograft dysfunction (CLAD) is lung transplant rejection causing airflow obstruction. Tailoring treatments to unique CLAD phenotypes is crucial, as prevention is key due to poor treatment response.

Keywords:
azithromycin responsive allograft dysfunctionbronchiolitis obliteransbronchiolitis obliterans syndromechronic lung allograft dysfunctionneutrophilic reversible allograft dysfunctionrestrictive allograft syndrome

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
04:42

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

Published on: March 21, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 8, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.2K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
04:42

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

Published on: March 21, 2025

1.4K

Area of Science:

  • Medicine
  • Immunology
  • Transplantation

Background:

  • Chronic lung allograft dysfunction (CLAD) impairs transplanted lung function, often due to chronic rejection.
  • CLAD presents with airflow restriction/obstruction, significantly impacting long-term transplant success.
  • Three distinct CLAD phenotypes (bronchiolitis obliterans, neutrophilic reversible allograft dysfunction, restrictive allograft syndrome) are now recognized.

Purpose of the Study:

  • To highlight the distinct pathologies of recognized CLAD phenotypes.
  • To emphasize the need for tailored treatment strategies based on specific CLAD etiology.
  • To underscore the critical importance of preventing CLAD due to limited treatment efficacy.

Main Methods:

  • Review of recent investigations into CLAD phenotypes.
  • Analysis of histopathological findings associated with different CLAD types.
  • Examination of contributions from small and large animal models in CLAD research.

Main Results:

  • Each CLAD phenotype exhibits unique pathology and histopathological characteristics.
  • Understanding these differences suggests the necessity for individualized treatment approaches.
  • CLAD is challenging to treat effectively once established, reinforcing prevention importance.

Conclusions:

  • Tailoring treatments to specific CLAD phenotypes is essential for improving outcomes.
  • Preventing CLAD development is paramount due to its poor response to interventions.
  • Further research, including animal models, is needed to develop effective human treatments.